Efficacy of Emicizumab Prophylaxis Versus Factor VIII Prophylaxis for Treatment of Hemophilia a Without Inhibitors: Network Meta-Analysis and Subgroup Analyses of the Intra-Patient Comparison of the HAVEN 3 Trial
Current Medical Research and Opinion - United Kingdom
doi 10.1080/03007995.2019.1649378
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 13, 2019
Authors
Publisher
Informa UK Limited